Vineet Laboratories Past Earnings Performance
Past criteria checks 5/6
Vineet Laboratories has been growing earnings at an average annual rate of 13.5%, while the Pharmaceuticals industry saw earnings growing at 14.8% annually. Revenues have been declining at an average rate of 6.8% per year. Vineet Laboratories's return on equity is 7.6%, and it has net margins of 1.6%.
Key information
13.5%
Earnings growth rate
15.0%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | -6.8% |
| Return on equity | 7.6% |
| Net Margin | 1.6% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Vineet Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,707 | 27 | 62 | 0 |
| 30 Sep 23 | 2,049 | 61 | 64 | 0 |
| 30 Jun 23 | 2,010 | -10 | 62 | 0 |
| 31 Mar 23 | 2,123 | 13 | 61 | 0 |
| 31 Dec 22 | 2,107 | 10 | 56 | 0 |
| 30 Sep 22 | 1,823 | 10 | 47 | 0 |
| 30 Jun 22 | 1,823 | 64 | 46 | 0 |
| 31 Mar 22 | 1,912 | 66 | 58 | 0 |
| 31 Mar 21 | 2,435 | 18 | 56 | 0 |
Quality Earnings: VINEETLAB has high quality earnings.
Growing Profit Margin: VINEETLAB's current net profit margins (1.6%) are higher than last year (0.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VINEETLAB's earnings have grown by 13.5% per year over the past 5 years.
Accelerating Growth: VINEETLAB's earnings growth over the past year (169.4%) exceeds its 5-year average (13.5% per year).
Earnings vs Industry: VINEETLAB earnings growth over the past year (169.4%) exceeded the Pharmaceuticals industry 23.8%.
Return on Equity
High ROE: VINEETLAB's Return on Equity (7.6%) is considered low.